{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T23:01:21Z","timestamp":1769641281540,"version":"3.49.0"},"reference-count":360,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.bcp.2018.01.042","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T10:12:08Z","timestamp":1518603128000},"page":"205-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["The dichotomous role of H2S in cancer cell biology? D\u00e9j\u00e0 vu all over again"],"prefix":"10.1016","volume":"149","author":[{"given":"Khosrow","family":"Kashfi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2018.01.042_b0005","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1073\/pnas.84.24.9265","article-title":"Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide","volume":"84","author":"Ignarro","year":"1987","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cardiores.2004.03.014","article-title":"NO suppresses while peroxynitrite sustains NF-kappaB: a paradigm to rationalize cytoprotective and cytotoxic actions attributed to NO","volume":"63","author":"Hattori","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0015","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/01.ATV.18.11.1796","article-title":"NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha","volume":"18","author":"Katsuyama","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0020","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.4049\/jimmunol.151.7.3767","article-title":"Modulation of rat mast cell reactivity by IL-1 beta. Divergent effects on nitric oxide and platelet-activating factor release","volume":"151","author":"Hogaboam","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2018.01.042_b0025","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0016-5085(98)70422-6","article-title":"Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer","volume":"114","author":"Huang","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2018.01.042_b0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mam.2004.09.003","article-title":"The role of nitric oxide in cardiovascular diseases","volume":"26","author":"Naseem","year":"2005","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.bcp.2018.01.042_b0035","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/gast.2000.9304","article-title":"Nitric oxide in mucosal defense: a little goes a long way","volume":"119","author":"Wallace","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2018.01.042_b0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tips.2009.01.001","article-title":"Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis","volume":"30","author":"Wallace","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2018.01.042_b0045","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1523\/JNEUROSCI.16-03-01066.1996","article-title":"The possible role of hydrogen sulfide as an endogenous neuromodulator","volume":"16","author":"Abe","year":"1996","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.bcp.2018.01.042_b0050","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1096\/fj.02-0211hyp","article-title":"Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?","volume":"16","author":"Wang","year":"2002","journal-title":"FASEB J. Off. Pub. Federat. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0055","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1093\/emboj\/20.21.6008","article-title":"The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener","volume":"20","author":"Zhao","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2018.01.042_b0060","doi-asserted-by":"crossref","first-page":"15560","DOI":"10.1073\/pnas.0705891104","article-title":"Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function","volume":"104","author":"Elrod","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b0065","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1096\/fj.06-6270fje","article-title":"Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation","volume":"20","author":"Zanardo","year":"2006","journal-title":"FASEB J. Off. Pub. Federat. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1089\/ars.2011.4351","article-title":"Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury","volume":"17","author":"Wallace","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2018.01.042_b0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.cr.7290133","article-title":"The role of nitric oxide in cancer","volume":"12","author":"Xu","year":"2002","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0080","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1089\/ars.2006.8.1329","article-title":"The biphasic nature of nitric oxide responses in tumor biology","volume":"8","author":"Ridnour","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2018.01.042_b0085","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/carcin\/19.5.711","article-title":"The multifaceted roles of nitric oxide in cancer","volume":"19","author":"Wink","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2018.01.042_b0090","series-title":"Cancer Sensitizing Agents for Chemotherapy","first-page":"105","article-title":"NO-H2S-releasing chimeras as a multifaceted approach to cancer therapy","author":"Kashfi","year":"2017"},{"key":"10.1016\/j.bcp.2018.01.042_b0095","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.tips.2007.09.003","article-title":"Hydrogen sulfide-releasing anti-inflammatory drugs","volume":"28","author":"Wallace","year":"2007","journal-title":"Trends Pharmacol. Sci"},{"key":"10.1016\/j.bcp.2018.01.042_b0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.coph.2005.10.007","article-title":"Hydrogen sulphide \u2013 a novel mediator of inflammation?","volume":"6","author":"Li","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/shk.0b013e31806ec26","article-title":"Treatment with H2S-releasing diclofenac protects mice against acute pancreatitis-associated lung injury","volume":"29","author":"Bhatia","year":"2008","journal-title":"Shock"},{"key":"10.1016\/j.bcp.2018.01.042_b0110","first-page":"623","article-title":"Role of hydrogen sulfide in acute pancreatitis and associated lung injury","volume":"19","author":"Bhatia","year":"2005","journal-title":"FASEB J. Off. Pub. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1582-4934.2007.00024.x","article-title":"Hydrogen sulfide acts as a mediator of inflammation in acute pancreatitis: in vitro studies using isolated mouse pancreatic acinar cells","volume":"11","author":"Tamizhselvi","year":"2007","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2018.01.042_b0120","article-title":"A timeline of hydrogen sulfide (H2S) research: from environmental toxin to biological mediator","author":"Szabo","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b0125","series-title":"Nitric Oxide Donors: Novel Biomedical Applications","first-page":"75","article-title":"Nitric oxide donors and therapeutic applications in cancer","author":"Kashfi","year":"2017"},{"key":"10.1016\/j.bcp.2018.01.042_b0130","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrd3228","article-title":"The therapeutic potential of carbon monoxide","volume":"9","author":"Motterlini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2018.01.042_b0135","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1016\/S0021-9258(18)63477-5","article-title":"Microsomal heme oxygenase. Characterization of the enzyme","volume":"244","author":"Tenhunen","year":"1969","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.01.042_b0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/10715769900301031","article-title":"The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis","volume":"31","author":"Foresti","year":"1999","journal-title":"Free Rad. Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0145","doi-asserted-by":"crossref","first-page":"L1029","DOI":"10.1152\/ajplung.2000.279.6.L1029","article-title":"Heme oxygenase: colors of defense against cellular stress","volume":"279","author":"Otterbein","year":"2000","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.bcp.2018.01.042_b0150","first-page":"974","article-title":"Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells","volume":"51","author":"Applegate","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0155","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev.pharmtox.37.1.517","article-title":"The heme oxygenase system: a regulator of second messenger gases","volume":"37","author":"Maines","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2018.01.042_b0160","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1039\/b704873d","article-title":"CO and NO in medicine","author":"Mann","year":"2007","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bcp.2018.01.042_b0165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.57.4.3","article-title":"Carbon monoxide: endogenous production, physiological functions, and pharmacological applications","volume":"57","author":"Wu","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2018.01.042_b0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd.2015.1","article-title":"Gasotransmitters in cancer: from pathophysiology to experimental therapy","volume":"15","author":"Szabo","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2018.01.042_b0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cbi.2014.04.006","article-title":"Hydrogen sulfide in hemostasis: Friend or foe?","volume":"217","author":"Olas","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2018.01.042_b0180","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"The L-arginine-nitric oxide pathway","volume":"329","author":"Moncada","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2018.01.042_b0185","first-page":"31","article-title":"Endothelium-derived nitric oxide: actions and properties","volume":"3","author":"Ignarro","year":"1989","journal-title":"FASEB J. Off. Pub. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0190","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev.pharmtox.37.1.339","article-title":"Structure-function aspects in the nitric oxide synthases","volume":"37","author":"Stuehr","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2018.01.042_b0195","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/21224","article-title":"Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation","volume":"399","author":"Dimmeler","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2018.01.042_b0200","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1242\/jcs.01165","article-title":"eNOS at a glance","volume":"117","author":"Sessa","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2018.01.042_b0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1023\/A:1005940202801","article-title":"Molecular biology of nitric oxide synthases","volume":"17","author":"Geller","year":"1998","journal-title":"Cancer Metast. Rev."},{"key":"10.1016\/j.bcp.2018.01.042_b0210","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj3570593","article-title":"Nitric oxide synthases: structure, function and inhibition","volume":"357","author":"Alderton","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2018.01.042_b0215","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.RES.0000082524.34487.31","article-title":"Regulation of nitric oxide-sensitive guanylyl cyclase","volume":"93","author":"Friebe","year":"2003","journal-title":"Circul. Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0220","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1538-7836.2010.03806.x","article-title":"Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition","volume":"8","author":"Dangel","year":"2010","journal-title":"J. Thromb. Haemost. JTH"},{"key":"10.1016\/j.bcp.2018.01.042_b0225","series-title":"Biochemistry of Smooth Muscle Contraction","article-title":"The nitric oxide-cyclic GMP signaling system","author":"Lincoln","year":"1996"},{"key":"10.1016\/j.bcp.2018.01.042_b0230","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0092-8674(94)90266-6","article-title":"Nitric oxide synthases: roles, tolls, and controls","volume":"78","author":"Nathan","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2018.01.042_b0235","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1515\/BC.2003.152","article-title":"Regulation of the expression of inducible nitric oxide synthase","volume":"384","author":"Kleinert","year":"2003","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bcp.2018.01.042_b0240","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1172\/JCI119750","article-title":"Nitric oxide synthases: which, where, how, and why?","volume":"100","author":"Michel","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2018.01.042_b0245","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2567.2004.01984.x","article-title":"Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle","volume":"113","author":"Kolios","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.bcp.2018.01.042_b0250","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.semnephrol.2004.04.003","article-title":"NO bioavailability, endothelial dysfunction, and acute renal failure: new insights into pathophysiology","volume":"24","author":"Goligorsky","year":"2004","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.bcp.2018.01.042_b0255","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/A:1005912906436","article-title":"Role of nitric oxide in tumour progression: lessons from human tumours","volume":"17","author":"Thomsen","year":"1998","journal-title":"Cancer Metast. Rev."},{"key":"10.1016\/j.bcp.2018.01.042_b0260","first-page":"6073","article-title":"Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets","volume":"51","author":"Radomski","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0265","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.redox.2015.08.009","article-title":"The dual role of iNOS in cancer","volume":"6","author":"Vannini","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0270","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2174\/1566524011313080002","article-title":"iNOS: a potential therapeutic target for malignant glioma","volume":"13","author":"Jahani-Asl","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.bcp.2018.01.042_b0275","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1073\/pnas.1401799111","article-title":"Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression","volume":"111","author":"Heinecke","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b0280","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1073\/pnas.92.10.4392","article-title":"Roles of nitric oxide in tumor growth","volume":"92","author":"Jenkins","year":"1995","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b0285","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13058-015-0527-x","article-title":"Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer","volume":"17","author":"Granados-Principal","year":"2015","journal-title":"BCR"},{"key":"10.1016\/j.bcp.2018.01.042_b0290","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm954","article-title":"Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation","volume":"9","author":"Cosby","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2018.01.042_b0295","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.niox.2013.11.002","article-title":"Mechanisms of nitrite bioactivation","volume":"38","author":"Kim-Shapiro","year":"2014","journal-title":"Nitric Oxide: Biol. Chem. Off. J. Nitric Oxide Soc."},{"key":"10.1016\/j.bcp.2018.01.042_b0300","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cbpb.2005.04.016","article-title":"Hemoglobin mediated nitrite activation of soluble guanylyl cyclase","volume":"142","author":"Jeffers","year":"2005","journal-title":"Comp. Biochem. Physiol. Part A, Mol. Integ. Physiol."},{"key":"10.1016\/j.bcp.2018.01.042_b0305","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1165\/rcmb.F299","article-title":"Nitric oxide, hemoglobin, and hypoxic vasodilation","volume":"32","author":"Gow","year":"2005","journal-title":"Am. J. Resp. Cell Mol. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0310","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nchembio.2007.46","article-title":"Catalytic generation of N2O3 by the concerted nitrite reductase and anhydrase activity of hemoglobin","volume":"3","author":"Basu","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0315","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.niox.2006.01.012","article-title":"S-nitrosohemoglobin: a mechanism for its formation in conjunction with nitrite reduction by deoxyhemoglobin","volume":"15","author":"Nagababu","year":"2006","journal-title":"Nitric oxide: Biol. Chem. Off. J. Nitric Oxide Soc."},{"key":"10.1016\/j.bcp.2018.01.042_b0320","doi-asserted-by":"crossref","first-page":"8366","DOI":"10.1073\/pnas.0600942103","article-title":"An S-nitrosothiol (SNO) synthase function of hemoglobin that utilizes nitrite as a substrate","volume":"103","author":"Angelo","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b0325","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/cvr\/cvq323","article-title":"The potential role of the red blood cell in nitrite-dependent regulation of blood flow","volume":"89","author":"Patel","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0330","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/01.RES.0000260171.52224.6b","article-title":"Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration","volume":"100","author":"Shiva","year":"2007","journal-title":"Circul. Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0335","doi-asserted-by":"crossref","first-page":"10256","DOI":"10.1073\/pnas.0801336105","article-title":"Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury","volume":"105","author":"Hendgen-Cotta","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b0340","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/CIRCULATIONAHA.111.087155","article-title":"Nitrite regulates hypoxic vasodilation via myoglobin-dependent nitric oxide generation","volume":"126","author":"Totzeck","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2018.01.042_b0345","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/364626a0","article-title":"A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds","volume":"364","author":"Lipton","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2018.01.042_b0350","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0092-8674(94)90269-0","article-title":"Redox signaling: nitrosylation and related target interactions of nitric oxide","volume":"78","author":"Stamler","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2018.01.042_b0355","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1126\/science.1281928","article-title":"Biochemistry of nitric oxide and its redox-activated forms","volume":"258","author":"Stamler","year":"1992","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.bcp.2018.01.042_b0360","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s000180050354","article-title":"S-nitrosylation of proteins","volume":"55","author":"Broillet","year":"1999","journal-title":"CMLS"},{"key":"10.1016\/j.bcp.2018.01.042_b0365","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrm1569","article-title":"Protein S-nitrosylation: purview and parameters","volume":"6","author":"Hess","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0370","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.RES.0000188210.72062.10","article-title":"Redox-dependent transcriptional regulation","volume":"97","author":"Liu","year":"2005","journal-title":"Circul. Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0375","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.02.053","article-title":"S-nitrosylation of the death receptor fas promotes fas ligand-mediated apoptosis in cancer cells","volume":"140","author":"Leon-Bollotte","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2018.01.042_b0380","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1128\/MCB.00199-06","article-title":"Nitrosylcobalamin promotes cell death via S nitrosylation of Apo2L\/TRAIL receptor DR4","volume":"26","author":"Tang","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0385","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1172\/JCI42059","article-title":"Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients","volume":"120","author":"Glynn","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2018.01.042_b0390","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1007\/s000180050357","article-title":"Peroxynitrite: an endogenous oxidizing and nitrating agent","volume":"55","author":"Ducrocq","year":"1999","journal-title":"CMLS"},{"key":"10.1016\/j.bcp.2018.01.042_b0395","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrd2222","article-title":"Peroxynitrite: biochemistry, pathophysiology and development of therapeutics","volume":"6","author":"Szabo","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2018.01.042_b0400","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.febslet.2004.06.055","article-title":"NO-degradation by alfalfa class 1 hemoglobin (Mhb1): a possible link to PR-1a gene expression in Mhb1-overproducing tobacco plants","volume":"571","author":"Seregelyes","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2018.01.042_b0405","first-page":"019","article-title":"Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras","volume":"24","author":"Kashfi","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b0410","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1006\/prep.1994.1063","article-title":"Expression of human cystathionine beta-synthase in Escherichia coli: purification and characterization","volume":"5","author":"Bukovska","year":"1994","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bcp.2018.01.042_b0415","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/bj2690335","article-title":"Sequence of cDNA for rat cystathionine gamma-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes","volume":"269","author":"Erickson","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2018.01.042_b0420","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/ars.2008.2253","article-title":"3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain","volume":"11","author":"Shibuya","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2018.01.042_b0425","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.tibs.2015.08.007","article-title":"H2S: A novel gasotransmitter that signals by sulfhydration","volume":"40","author":"Paul","year":"2015","journal-title":"Trend. Biochem. Sci."},{"key":"10.1016\/j.bcp.2018.01.042_b0430","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molcel.2011.10.021","article-title":"Hydrogen sulfide-linked sulfhydration of NF-kappaB mediates its antiapoptotic actions","volume":"45","author":"Sen","year":"2012","journal-title":"Mol. cell"},{"key":"10.1016\/j.bcp.2018.01.042_b0435","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00018-009-0250-9","article-title":"Glucocorticoids suppress cystathionine gamma-lyase expression and H2S production in lipopolysaccharide-treated macrophages","volume":"67","author":"Zhu","year":"2010","journal-title":"CMLS"},{"key":"10.1016\/j.bcp.2018.01.042_b0440","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cell.2014.11.048","article-title":"Endogenous hydrogen sulfide production is essential for dietary restriction benefits","volume":"160","author":"Hine","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2018.01.042_b0445","first-page":"4:ra86","article-title":"H2S-Induced sulfhydration of the phosphatase PTP1B and its role in the endoplasmic reticulum stress response","author":"Krishnan","year":"2011","journal-title":"Sci. Sig."},{"key":"10.1016\/j.bcp.2018.01.042_b0450","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0003-2697(91)90295-5","article-title":"Biological sulfane sulfur","volume":"195","author":"Westley","year":"1991","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bcp.2018.01.042_b0455","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/(SICI)1097-010X(19981015)282:3<310::AID-JEZ4>3.0.CO;2-P","article-title":"Sulfur reduction by human erythrocytes","volume":"282","author":"Searcy","year":"1998","journal-title":"J. Exp. Zool."},{"key":"10.1016\/j.bcp.2018.01.042_b0460","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.redox.2013.05.001","article-title":"A tale of two gases: NO and H2S, foes or friends for life?","volume":"1","author":"Kolluru","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0465","article-title":"H2S and polysulfide metabolism: conventional and unconventional pathways","author":"Olson","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b0470","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/ncomms2371","article-title":"A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells","volume":"4","author":"Shibuya","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2018.01.042_b0475","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fendo.2013.00087","article-title":"Production of hydrogen sulfide from d-cysteine and its therapeutic potential","volume":"4","author":"Shibuya","year":"2013","journal-title":"Frontiers in endocrinology"},{"key":"10.1016\/j.bcp.2018.01.042_b0480","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1083\/jcb.107.3.897","article-title":"Identification of peroxisomal targeting signals located at the carboxy terminus of four peroxisomal proteins","volume":"107","author":"Gould","year":"1988","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0485","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/ars.2014.6082","article-title":"Signaling of hydrogen sulfide and polysulfides","volume":"22","author":"Kimura","year":"2015","journal-title":"Antiox. Redox Signal."},{"key":"10.1016\/j.bcp.2018.01.042_b0490","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1073\/pnas.1306241110","article-title":"Tumor-derived hydrogen sulfide, produced by cystathionine-beta-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer","volume":"110","author":"Szabo","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b0495","doi-asserted-by":"crossref","first-page":"e79167","DOI":"10.1371\/journal.pone.0079167","article-title":"Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance","volume":"8","author":"Bhattacharyya","year":"2013","journal-title":"PloS one"},{"issue":"483","key":"10.1016\/j.bcp.2018.01.042_b0500","first-page":"e1","article-title":"Characterization of hydrogen sulfide and its synthases, cystathionine beta-synthase and cystathionine gamma-lyase, in human prostatic tissue and cells","volume":"79","author":"Guo","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.bcp.2018.01.042_b0505","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2015.05.024","article-title":"Role of cystathionine beta-synthase in human breast Cancer","volume":"86","author":"Sen","year":"2015","journal-title":"Free Rad. Biol. Med."},{"key":"10.1016\/j.bcp.2018.01.042_b0510","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1042\/CS20150521","article-title":"Cystathionine beta-synthase-derived hydrogen sulfide is involved in human malignant hyperthermia","volume":"130","author":"Vellecco","year":"2016","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bcp.2018.01.042_b0515","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1038\/sj.onc.1205868","article-title":"Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays","volume":"21","author":"De Vos","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2018.01.042_b0520","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-319-18144-8_12","article-title":"Hydrogen Sulfide and Cancer","volume":"230","author":"Hellmich","year":"2015","journal-title":"Handb. Exp. Pharm."},{"key":"10.1016\/j.bcp.2018.01.042_b0525","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/ars.2014.5933","article-title":"The therapeutic potential of cystathionine beta-synthetase\/hydrogen sulfide inhibition in cancer","volume":"22","author":"Hellmich","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2018.01.042_b0530","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/pcmr.12312","article-title":"Role of the cystathionine gamma lyase\/hydrogen sulfide pathway in human melanoma progression","volume":"28","author":"Panza","year":"2015","journal-title":"Pig. Cell Melan. Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0535","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00726-010-0606-3","article-title":"The expression and activity of cystathionine-gamma-lyase and 3-mercaptopyruvate sulfurtransferase in human neoplastic cell lines","volume":"41","author":"Jurkowska","year":"2011","journal-title":"Amino acids"},{"key":"10.1016\/j.bcp.2018.01.042_b0540","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1124\/mol.105.017467","article-title":"Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells","volume":"68","author":"Tang","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b0545","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrd4433","article-title":"Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter","volume":"14","author":"Wallace","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2018.01.042_b0550","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00125-012-2806-8","article-title":"Hydrogen sulfide-induced inhibition of L-type Ca2+ channels and insulin secretion in mouse pancreatic beta cells","volume":"56","author":"Tang","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2018.01.042_b0555","doi-asserted-by":"crossref","first-page":"e37073","DOI":"10.1371\/journal.pone.0037073","article-title":"Hydrogen sulfide inhibits L-type calcium currents depending upon the protein sulfhydryl state in rat cardiomyocytes","volume":"7","author":"Zhang","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.bcp.2018.01.042_b0560","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbrc.2014.01.185","article-title":"Endogenous and exogenous hydrogen sulfide facilitates T-type calcium channel currents in Cav3.2-expressing HEK293 cells","volume":"445","author":"Sekiguchi","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2018.01.042_b0565","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pain.2008.12.021","article-title":"Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels","volume":"142","author":"Maeda","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2018.01.042_b0570","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.freeradbiomed.2009.09.018","article-title":"Making and working with hydrogen sulfide: The chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: a review","volume":"47","author":"Hughes","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2018.01.042_b0575","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1061\/JSEDAI.0001372","article-title":"Oxidation of sulfide by O2: catalysis and inhibition","volume":"98","author":"Chen","year":"1972","journal-title":"J. Sanit. Eng. Div."},{"key":"10.1016\/j.bcp.2018.01.042_b0580","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1111\/j.1742-4658.2008.06482.x","article-title":"Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria","volume":"275","author":"Hildebrandt","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2018.01.042_b0585","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1096-4959(01)00309-8","article-title":"Sulfide oxidation coupled to ATP synthesis in chicken liver mitochondria","volume":"129","author":"Yong","year":"2001","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0590","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1021\/acs.biochem.6b01093","article-title":"Use of tissue metabolite analysis and enzyme kinetics to discriminate between alternate pathways for hydrogen sulfide metabolism","volume":"56","author":"Augustyn","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2018.01.042_b0595","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1242\/jeb.128.1.139","article-title":"The sulphide-binding protein in the blood of the vestimentiferan tubeworm, Riftia pachyptila, is the extracellular hemoglobin","volume":"128","author":"Arp","year":"1987","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/y97-187","article-title":"Resurgence of carbon monoxide: an endogenous gaseous vasorelaxing factor","volume":"76","author":"Wang","year":"1998","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b0605","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1152\/physrev.00017.2011","article-title":"Physiological implications of hydrogen sulfide: a whiff exploration that blossomed","volume":"92","author":"Wang","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2018.01.042_b0610","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1089\/ars.2012.4783","article-title":"Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease","volume":"18","author":"Nussbaum","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2018.01.042_b0615","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/bph.12769","article-title":"Interactions of hydrogen sulfide with myeloperoxidase","volume":"172","author":"Palinkas","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b0620","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1016\/j.bmcl.2009.09.030","article-title":"Hydrogen sulfide induces nitric oxide release from nitrite","volume":"19","author":"Grossi","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2018.01.042_b0625","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1073\/pnas.1206646109","article-title":"Shared signaling pathways among gasotransmitters","volume":"109","author":"Wang","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b0630","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.niox.2014.05.014","article-title":"Hydrogen sulfide and nitric oxide interactions in inflammation","volume":"41","author":"Lo Faro","year":"2014","journal-title":"Nitric oxide Biol. Chem. Off. J. Nitric Oxide Soc."},{"key":"10.1016\/j.bcp.2018.01.042_b0635","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0162-0134(01)00335-X","article-title":"Characterization of NO binding to human cystathionine beta-synthase: possible implications of the effects of CO and NO binding to the human enzyme","volume":"87","author":"Taoka","year":"2001","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bcp.2018.01.042_b0640","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tox.2006.12.023","article-title":"Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension","volume":"232","author":"Kubo","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2018.01.042_b0645","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tox.2007.08.087","article-title":"Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase","volume":"241","author":"Kubo","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2018.01.042_b0650","doi-asserted-by":"crossref","first-page":"H474","DOI":"10.1152\/ajpheart.00013.2002","article-title":"H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms","volume":"283","author":"Zhao","year":"2002","journal-title":"Am. J. Physiol. Heart Circul. Physiol."},{"key":"10.1016\/j.bcp.2018.01.042_b0655","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bbrc.2006.05.002","article-title":"Hydrogen sulfide potentiates interleukin-1beta-induced nitric oxide production via enhancement of extracellular signal-regulated kinase activation in rat vascular smooth muscle cells","volume":"345","author":"Jeong","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2018.01.042_b0660","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fphys.2011.00104","article-title":"Hydrogen sulfide increases nitric oxide production from endothelial cells by an akt-dependent mechanism","volume":"2","author":"Predmore","year":"2011","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2018.01.042_b0665","first-page":"211","article-title":"Hydrogen sulfide increases nitric oxide production with calcium-dependent activation of endothelial nitric oxide synthase in endothelial cells","volume":"48","author":"Kida","year":"2013","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.bcp.2018.01.042_b0670","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/jcmm.12077","article-title":"Crosstalk between hydrogen sulfide and nitric oxide in endothelial cells","volume":"17","author":"Altaany","year":"2013","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bcp.2018.01.042_b0675","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1073\/pnas.1202916109","article-title":"Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation","volume":"109","author":"Coletta","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b0680","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bbrc.2006.02.154","article-title":"Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide","volume":"343","author":"Whiteman","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2018.01.042_b0685","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/cvr\/cvq248","article-title":"Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl","volume":"88","author":"Yong","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0690","doi-asserted-by":"crossref","first-page":"12016","DOI":"10.1021\/ja3009693","article-title":"Chemical characterization of the smallest S-nitrosothiol, HSNO; cellular cross-talk of H2S and S-nitrosothiols","volume":"134","author":"Filipovic","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bcp.2018.01.042_b0695","doi-asserted-by":"crossref","first-page":"45995","DOI":"10.1038\/srep45995","article-title":"Polysulfides (H2Sn) produced from the interaction of hydrogen sulfide (H2S) and nitric oxide (NO) activate TRPA1 channels","volume":"7","author":"Miyamoto","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2018.01.042_b0700","first-page":"2451","article-title":"Polysulfides are possible H2S-derived signaling molecules in rat brain","volume":"27","author":"Kimura","year":"2013","journal-title":"FASEB J. Off. Pub. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0705","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12990-015-0023-4","article-title":"Polysulfide evokes acute pain through the activation of nociceptive TRPA1 in mouse sensory neurons","volume":"11","author":"Hatakeyama","year":"2015","journal-title":"Mol. pain"},{"key":"10.1016\/j.bcp.2018.01.042_b0710","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1016\/j.febslet.2013.09.013","article-title":"Polysulfide exerts a protective effect against cytotoxicity caused by t-buthylhydroperoxide through Nrf2 signaling in neuroblastoma cells","volume":"587","author":"Koike","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2018.01.042_b0715","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1089\/ars.2012.5041","article-title":"Polysulfides link H2S to protein thiol oxidation","volume":"19","author":"Greiner","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2018.01.042_b0720","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1161\/HYPERTENSIONAHA.114.04281","article-title":"Protein kinase G Ialpha oxidation paradoxically underlies blood pressure lowering by the reductant hydrogen sulfide","volume":"64","author":"Stubbert","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2018.01.042_b0725","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.freeradbiomed.2015.09.007","article-title":"Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is inactivated by S-sulfuration in vitro","volume":"89","author":"Jarosz","year":"2015","journal-title":"Free Rad. Biol. Med."},{"key":"10.1016\/j.bcp.2018.01.042_b0730","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.redox.2013.12.031","article-title":"Nitrosopersulfide (SSNO(\u2212)) accounts for sustained NO bioactivity of S-nitrosothiols following reaction with sulfide","volume":"2","author":"Cortese-Krott","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0735","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1509277112","article-title":"Key bioactive reaction products of the NO\/H2S interaction are S\/N-hybrid species, polysulfides, and nitroxyl","author":"Cortese-Krott","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b0740","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00424-008-0519-0","article-title":"H(2)S and HS(-) donor NaHS releases nitric oxide from nitrosothiols, metal nitrosyl complex, brain homogenate and murine L1210 leukaemia cells","volume":"457","author":"Ondrias","year":"2008","journal-title":"Pflugers Archiv. Eur. J. Physiol."},{"key":"10.1016\/j.bcp.2018.01.042_b0745","first-page":"2462","article-title":"Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms","volume":"54","author":"Cui","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0750","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.cdd.4400582","article-title":"Nitric oxide (NO): an effector of apoptosis","volume":"6","author":"Brune","year":"1999","journal-title":"Cell Death Different."},{"key":"10.1016\/j.bcp.2018.01.042_b0755","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/bjc.1995.274","article-title":"Nitric oxide synthase activity in human breast cancer","volume":"72","author":"Thomsen","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2018.01.042_b0760","article-title":"NOS2-derived NO drives multiple pathways of breast cancer progression","author":"Basudhar","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2018.01.042_b0765","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1897::AID-CNCR12>3.0.CO;2-O","article-title":"Selective expression of inducible nitric oxide synthase in human prostate carcinoma","volume":"82","author":"Klotz","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2018.01.042_b0770","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1164\/rccm.200411-1523OC","article-title":"Abnormalities in nitric oxide and its derivatives in lung cancer","volume":"172","author":"Masri","year":"2005","journal-title":"Am. J. Respirat. Crit. Care Med."},{"key":"10.1016\/j.bcp.2018.01.042_b0775","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/jnci\/90.8.587","article-title":"Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer","volume":"90","author":"Gallo","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bcp.2018.01.042_b0780","first-page":"334","article-title":"Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression","volume":"58","author":"Ambs","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0785","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1177\/000313480106700726","article-title":"Nitric oxide synthase as a marker in colorectal carcinoma","volume":"67","author":"Lagares-Garcia","year":"2001","journal-title":"Am. Surg."},{"key":"10.1016\/j.bcp.2018.01.042_b0790","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.semcancer.2005.04.004","article-title":"Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin","volume":"15","author":"Lechner","year":"2005","journal-title":"Sem. Cancer Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0795","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tranon.2014.02.001","article-title":"The implications of hyponitroxia in cancer","volume":"7","author":"Oronsky","year":"2014","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bcp.2018.01.042_b0800","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0022-3565(24)29198-9","article-title":"Post-translational control of endothelial nitric oxide synthase: why isn't calcium\/calmodulin enough?","volume":"299","author":"Fulton","year":"2001","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.bcp.2018.01.042_b0805","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1096\/fasebj.11.6.9194524","article-title":"Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression","volume":"11","author":"Ambs","year":"1997","journal-title":"FASEB J. Off. Pub. Federat. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0810","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.niox.2008.04.006","article-title":"Molecular mechanisms for discrete nitric oxide levels in cancer","volume":"19","author":"Ridnour","year":"2008","journal-title":"Nitric oxide Biol. Chem. Off. J. Nitric Oxide Soc."},{"key":"10.1016\/j.bcp.2018.01.042_b0815","first-page":"2531","article-title":"Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells","volume":"51","author":"Li","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0820","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.4049\/jimmunol.149.6.2137","article-title":"Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target","volume":"149","author":"Jiang","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2018.01.042_b0825","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-3083.1995.tb03687.x","article-title":"Nitric oxide synthase pathway may mediate human natural killer cell cytotoxicity","volume":"42","author":"Xiao","year":"1995","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bcp.2018.01.042_b0830","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/hep.510240124","article-title":"Role in nitric oxide in Kupffer cell-mediated hepatoma cell cytotoxicity in vitro and ex vivo","volume":"24","author":"Fukumura","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2018.01.042_b0835","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bjp.0707224","article-title":"Recent developments in nitric oxide donor drugs","volume":"151","author":"Miller","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b0840","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1477-7819-11-118","article-title":"Nitric oxide and cancer: a review","volume":"11","author":"Choudhari","year":"2013","journal-title":"W. J. Surg. Oncol."},{"key":"10.1016\/j.bcp.2018.01.042_b0845","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/gast.2002.34310","article-title":"Influence of the nitric oxide donor glyceryl trinitrate on apoptotic pathways in human colon cancer cells","volume":"123","author":"Millet","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2018.01.042_b0850","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/carcin\/22.8.1207","article-title":"Nitroglycerin: a NO donor inhibits TPA-mediated tumor promotion in murine skin","volume":"22","author":"Trikha","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2018.01.042_b0855","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1476-5381.1995.tb16670.x","article-title":"Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate","volume":"116","author":"Pipili-Synetos","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b0860","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1093\/carcin\/17.11.2477","article-title":"Histogenesis and the role of p53 and K-ras mutations in hepatocarcinogenesis by glyceryl trinitrate (nitroglycerin) in male F344 rats","volume":"17","author":"Tamano","year":"1996","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2018.01.042_b0865","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2893.2001.00269.x","article-title":"Levels of circulating endothelin-1 and nitrates\/nitrites in patients with virus-related hepatocellular carcinoma","volume":"8","author":"Notas","year":"2001","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.bcp.2018.01.042_b0870","first-page":"4471","article-title":"Nitric oxide-releasing medications and colorectal cancer risk: the framingham study","volume":"25","author":"Muscat","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0875","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1749-6632.1963.tb13299.x","article-title":"An approach to longitudinal studies in a community: the Framingham Study","volume":"107","author":"Dawber","year":"1963","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.bcp.2018.01.042_b0880","unstructured":"G. Wei, The Framingham Heart Study (FHS). Project Period: 9\/1\/1948\u20135\/1\/2015. 2015."},{"key":"10.1016\/j.bcp.2018.01.042_b0885","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.bcp.2018.01.042_b0890","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2018.01.042_b0895","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circul. Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0900","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1161\/01.ATV.15.10.1652","article-title":"Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia","volume":"15","author":"Gauthier","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0905","doi-asserted-by":"crossref","first-page":"24266","DOI":"10.1074\/jbc.273.37.24266","article-title":"Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase","volume":"273","author":"Laufs","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.01.042_b0910","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1056\/NEJMoa043792","article-title":"Statins and the risk of colorectal cancer","volume":"352","author":"Poynter","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2018.01.042_b0915","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/jgh.13393","article-title":"Statin use and the risk of colorectal adenoma: a meta-analysis","volume":"31","author":"Jung","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2018.01.042_b0920","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/CEJ.0000000000000152","article-title":"Statins in the chemoprevention of colorectal cancer in established animal models of sporadic and colitis-associated cancer","volume":"25","author":"Pikoulis","year":"2016","journal-title":"Eur. J. Cancer Prev. Off. j. Eur. Cancer Prev. Organis. (ECP)"},{"key":"10.1016\/j.bcp.2018.01.042_b0925","doi-asserted-by":"crossref","first-page":"695","DOI":"10.5414\/CPP42695","article-title":"Inhibitory effect of statins on the proliferation of human breast cancer cells","volume":"42","author":"Muck","year":"2004","journal-title":"Int. J. Clin. Pharmacol. Therap."},{"key":"10.1016\/j.bcp.2018.01.042_b0930","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.canlet.2006.10.009","article-title":"Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK","volume":"250","author":"Koyuturk","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2018.01.042_b0935","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1158\/1940-6207.CAPR-15-0300","article-title":"The effect of atorvastatin on breast cancer biomarkers in high-risk women","volume":"9","author":"Ji","year":"2016","journal-title":"Cancer prevention research"},{"key":"10.1016\/j.bcp.2018.01.042_b0940","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2174\/1871520613666131129105035","article-title":"Statins and cancer","volume":"14","author":"Vallianou","year":"2014","journal-title":"Anticancer Agent. Med. Chem."},{"key":"10.1016\/j.bcp.2018.01.042_b0945","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1158\/1535-7163.MCT-06-0175","article-title":"Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells","volume":"5","author":"Sivaprasad","year":"2006","journal-title":"Mol. Cancer Therap."},{"key":"10.1016\/j.bcp.2018.01.042_b0950","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.1158\/0008-5472.CAN-05-4061","article-title":"Breast cancer growth prevention by statins","volume":"66","author":"Campbell","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0955","first-page":"4885","article-title":"Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors","volume":"61","author":"Kusama","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0960","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/gast.2002.31093","article-title":"3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis","volume":"122","author":"Kusama","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2018.01.042_b0965","first-page":"3949","article-title":"HMG CoA reductase inhibitor fluvastatin arrests the development of implanted hepatocarcinoma in rats","volume":"23","author":"Paragh","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0970","doi-asserted-by":"crossref","first-page":"7386","DOI":"10.1158\/0008-5472.CAN-07-0993","article-title":"Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways","volume":"67","author":"Kotamraju","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0975","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.bjp.0706186","article-title":"Hydrogen sulphide is a mediator of carrageenan-induced hindpaw oedema in the rat","volume":"145","author":"Bhatia","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b0980","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1096\/fj.04-3583fje","article-title":"Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J. Off. Pub. Federat. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b0985","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/sj.bjp.0706696","article-title":"Nitric oxide-releasing flurbiprofen reduces formation of proinflammatory hydrogen sulfide in lipopolysaccharide-treated rat","volume":"147","author":"Anuar","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b0990","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s00011-006-5150-y","article-title":"Flurbiprofen and its nitric oxide-releasing derivative protect against septic shock in rats","volume":"55","author":"Anuar","year":"2006","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bcp.2018.01.042_b0995","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1471-4159.2004.02617.x","article-title":"The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'?","volume":"90","author":"Whiteman","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2018.01.042_b1000","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbrc.2004.11.110","article-title":"Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain?","volume":"326","author":"Whiteman","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2018.01.042_b1005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/08923979809034822","article-title":"Sulfide enhancement of PMN apoptosis","volume":"20","author":"Mariggio","year":"1998","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.bcp.2018.01.042_b1010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrd1383","article-title":"Inflammatory resolution: new opportunities for drug discovery","volume":"3","author":"Gilroy","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2018.01.042_b1015","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1471-4159.2006.04283.x","article-title":"Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia","volume":"100","author":"Hu","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2018.01.042_b1020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/mol.108.047985","article-title":"Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function","volume":"75","author":"Hu","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2174\/156652412798376099","article-title":"Nitric oxide and cancer: the emerging role of S-nitrosylation","volume":"12","author":"Aranda","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.bcp.2018.01.042_b1030","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0140-6736(86)92612-7","article-title":"Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision","volume":"2","author":"Quirke","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2018.01.042_b1035","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1073\/pnas.042671399","article-title":"Overhauser enhanced magnetic resonance imaging for tumor oximetry: coregistration of tumor anatomy and tissue oxygen concentration","volume":"99","author":"Krishna","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b1040","first-page":"3316","article-title":"Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements","volume":"51","author":"Vaupel","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b1045","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/186780a0","article-title":"Effect of oxygen and nitric oxide on the radio-sensitivity of human cells in tissue culture","volume":"186","author":"Dewey","year":"1960","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2018.01.042_b1050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bcp.2010.09.022","article-title":"DNA strand breaks and hypoxia response inhibition mediate the radiosensitisation effect of nitric oxide donors on prostate cancer under varying oxygen conditions","volume":"81","author":"Stewart","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1055","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1158\/0008-5472.CAN-04-2212","article-title":"Nitric oxide and ionizing radiation synergistically promote apoptosis and growth inhibition of cancer by activating p53","volume":"64","author":"Cook","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b1060","series-title":"Cancer Sensitizing Agents for Chemotherapy; Nitric Oxide (Donor\/Induced) in Chemosensitization","first-page":"15","article-title":"Nitric oxide donors sensitize resistant cancer cells to apoptosis induced by chemotherapy: molecular mechanisms of sensitization","author":"Bonavida","year":"2017"},{"key":"10.1016\/j.bcp.2018.01.042_b1065","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2018.01.042_b1070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1706","article-title":"Molecular mechanisms of drug resistance","volume":"205","author":"Longley","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.bcp.2018.01.042_b1075","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1158\/0008-5472.516.65.2","article-title":"Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux","volume":"65","author":"Riganti","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b1080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2018.01.042_b1085","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1073\/pnas.91.9.3497","article-title":"Cell biological mechanisms of multidrug resistance in tumors","volume":"91","author":"Simon","year":"1994","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b1090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.niox.2004.03.006","article-title":"Endogenous production and exogenous exposure to nitric oxide augment doxorubicin cytotoxicity for breast cancer cells but not cardiac myoblasts","volume":"10","author":"Evig","year":"2004","journal-title":"Nitric oxide Biol. Chem. Off. J. Nitric Oxide Soc."},{"key":"10.1016\/j.bcp.2018.01.042_b1095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.niox.2012.12.001","article-title":"Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer","volume":"29","author":"Huerta-Yepez","year":"2013","journal-title":"Nitric oxide Biol. Chem. Off. J. Nitric Oxide Soc."},{"key":"10.1016\/j.bcp.2018.01.042_b1100","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1038\/sj.onc.1207655","article-title":"Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression","volume":"23","author":"Huerta-Yepez","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2018.01.042_b1105","doi-asserted-by":"crossref","first-page":"8841","DOI":"10.1073\/pnas.0403034101","article-title":"S-nitrosylation: physiological regulation of NF-kappaB","volume":"101","author":"Marshall","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b1110","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/jpet.104.075994","article-title":"Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo","volume":"312","author":"Kashfi","year":"2005","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.bcp.2018.01.042_b1115","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1073\/pnas.0511250103","article-title":"Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin","volume":"103","author":"Bratasz","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b1120","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1158\/1535-7163.MCT-05-0536","article-title":"Efficacy of a nitric oxide-releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts","volume":"5","author":"Leonetti","year":"2006","journal-title":"Mol. Cancer Therap."},{"key":"10.1016\/j.bcp.2018.01.042_b1125","doi-asserted-by":"crossref","first-page":"43172","DOI":"10.18632\/oncotarget.6526","article-title":"Epigenetic effects of RRx-001: a possible unifying mechanism of anticancer activity","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2018.01.042_b1130","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1470-2045(15)00089-3","article-title":"Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study","volume":"16","author":"Reid","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcp.2018.01.042_b1135","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1159\/000449432","article-title":"Conversion of Platinum-Etoposide-Resistant to Sensitive SCLC after Treatment with the Epi-Immunotherapeutic RRx-001: A Case Report","volume":"39","author":"Brzezniak","year":"2016","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.bcp.2018.01.042_b1140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrd794","article-title":"Potential cardioprotective actions of no-releasing aspirin","volume":"1","author":"Wallace","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2018.01.042_b1145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1472-8206.2003.00125.x","article-title":"The therapeutic potential of NO-NSAIDs","volume":"17","author":"Wallace","year":"2003","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1054-3589(08)57002-5","article-title":"Anti-inflammatory agents as cancer therapeutics","volume":"57","author":"Kashfi","year":"2009","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1155","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1124\/jpet.102.042754","article-title":"Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect","volume":"303","author":"Kashfi","year":"2002","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.bcp.2018.01.042_b1160","first-page":"389","article-title":"Flurbiprofen benzyl nitrate (NBS-242) inhibits the growth of A-431 human epidermoid carcinoma cells and targets beta-catenin","volume":"7","author":"Nath","year":"2013","journal-title":"Drug des. Dev. Therap."},{"key":"10.1016\/j.bcp.2018.01.042_b1165","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.bcp.2005.05.004","article-title":"Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention","volume":"70","author":"Kashfi","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1170","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1021\/tx7002257","article-title":"Quinone formation as a chemoprevention strategy for hybrid drugs: balancing cytotoxicity and cytoprotection","volume":"20","author":"Dunlap","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bcp.2018.01.042_b1175","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1021\/jm061371e","article-title":"Chemical insights in the concept of hybrid drugs: the antitumor effect of nitric oxide-donating aspirin involves a quinone methide but not nitric oxide nor aspirin","volume":"50","author":"Hulsman","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2018.01.042_b1180","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.bbrc.2007.05.038","article-title":"The mechanism of action of nitric oxide-donating aspirin","volume":"358","author":"Kashfi","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"L","key":"10.1016\/j.bcp.2018.01.042_b1185","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0024-3205(98)00191-X","article-title":"Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma","volume":"62","author":"Bak","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2018.01.042_b1190","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bbrc.2003.12.015","article-title":"NO-donating aspirin inhibits intestinal carcinogenesis in Min (APC(Min\/+)) mice","volume":"313","author":"Williams","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2018.01.042_b1195","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1158\/1535-7163.MCT-06-0061","article-title":"Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets","volume":"5","author":"Rao","year":"2006","journal-title":"Mol. Cancer Therap."},{"key":"10.1016\/j.bcp.2018.01.042_b1200","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1158\/0008-5472.CAN-05-3118","article-title":"Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model","volume":"66","author":"Ouyang","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b1205","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/1940-6207.CAPR-13-0164","article-title":"Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model","volume":"7","author":"Nicastro","year":"2014","journal-title":"Cancer prevention research"},{"key":"10.1016\/j.bcp.2018.01.042_b1210","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.3390\/molecules200712481","article-title":"Nitric oxide-releasing aspirin suppresses NF-kappaB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo","volume":"20","author":"Nath","year":"2015","journal-title":"Mol."},{"key":"10.1016\/j.bcp.2018.01.042_b1215","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1021\/cb200274r","article-title":"Fifty years of diazeniumdiolate research. From laboratory curiosity to broad-spectrum biomedical advances","volume":"6","author":"Keefer","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b1220","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.bmc.2012.01.046","article-title":"Diazeniumdiolated carbamates: a novel class of nitric oxide donors","volume":"20","author":"Nandurdikar","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bcp.2018.01.042_b1225","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1073\/pnas.0937302100","article-title":"Positive inotropic and lusitropic effects of HNO\/NO- in failing hearts: independence from beta-adrenergic signaling","volume":"100","author":"Paolocci","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b1230","doi-asserted-by":"crossref","first-page":"10463","DOI":"10.1073\/pnas.181191198","article-title":"Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling","volume":"98","author":"Paolocci","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b1235","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1021\/jm00011a005","article-title":"Prodrugs of nitroxyl as potential aldehyde dehydrogenase inhibitors vis-a-vis vascular smooth muscle relaxants","volume":"38","author":"Nagasawa","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2018.01.042_b1240","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/ijc.23305","article-title":"Nitroxyl inhibits breast tumor growth and angiogenesis","volume":"122","author":"Norris","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2018.01.042_b1245","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1021\/jm400196q","article-title":"Synthesis and chemical and biological comparison of nitroxyl- and nitric oxide-releasing diazeniumdiolate-based aspirin derivatives","volume":"56","author":"Basudhar","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2018.01.042_b1250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2015.01.029","article-title":"Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer","volume":"83","author":"Basudhar","year":"2015","journal-title":"Free Rad. Biol. Med."},{"key":"10.1016\/j.bcp.2018.01.042_b1255","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1615\/ForumImmunDisTher.v1.i3.30","article-title":"Broad-spectrum anti-cancer activity of O-arylated diazeniumdiolates","volume":"1","author":"Keefer","year":"2010","journal-title":"Forum Immunopathol. Dis. Therap."},{"key":"10.1016\/j.bcp.2018.01.042_b1260","first-page":"409","article-title":"JS-K, a glutathione\/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity","volume":"2","author":"Shami","year":"2003","journal-title":"Mol. Cancer Therap."},{"key":"10.1016\/j.bcp.2018.01.042_b1265","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.leukres.2009.01.002","article-title":"JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C)","volume":"33","author":"Shami","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bcp.2018.01.042_b1270","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1124\/mol.65.5.1070","article-title":"Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug","volume":"65","author":"Findlay","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1275","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1021\/jm050700k","article-title":"PABA\/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity","volume":"49","author":"Saavedra","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2018.01.042_b1280","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1182\/blood-2006-10-052845","article-title":"JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells","volume":"110","author":"Kiziltepe","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2018.01.042_b1285","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1021\/jm060022h","article-title":"Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivo","volume":"49","author":"Shami","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2018.01.042_b1290","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.bmcl.2007.12.044","article-title":"Synthesis and in vitro anti-leukemic activity of structural analogues of JS-K, an anti-cancer lead compound","volume":"18","author":"Chakrapani","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2018.01.042_b1295","first-page":"963","article-title":"JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cells","volume":"38","author":"McMurtry","year":"2011","journal-title":"International journal of oncology"},{"key":"10.1016\/j.bcp.2018.01.042_b1300","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.redox.2012.12.002","article-title":"Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balance","volume":"1","author":"Maciag","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b1305","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.bcp.2010.08.011","article-title":"JS-K, a nitric oxide-releasing prodrug, modulates \u00df-catenin\/TCF signaling in leukemic Jurkat cells: evidence of an S-nitrosylated mechanism","volume":"80","author":"Nath","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1310","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbrc.2012.02.051","article-title":"NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model","volume":"419","author":"Chattopadhyay","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2018.01.042_b1315","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jhazmat.2004.06.002","article-title":"1,3,3-Trinitroazetidine (TNAZ), a melt-cast explosive: synthesis, characterization and thermal behaviour","volume":"113","author":"Sikder","year":"2004","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.bcp.2018.01.042_b1320","series-title":"Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof","author":"Knox","year":"2009"},{"key":"10.1016\/j.bcp.2018.01.042_b1325","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.freeradbiomed.2012.11.003","article-title":"Antioxidant functions for the hemoglobin beta93 cysteine residue in erythrocytes and in the vascular compartment in vivo","volume":"55","author":"Vitturi","year":"2013","journal-title":"Free Rad. Biol. Med."},{"key":"10.1016\/j.bcp.2018.01.042_b1330","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4155\/bio.13.331","article-title":"Development of methods for the bioanalysis of RRx-001 and metabolites","volume":"6","author":"Scicinski","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.bcp.2018.01.042_b1335","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1124\/dmd.112.046755","article-title":"Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agent","volume":"40","author":"Scicinski","year":"2012","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"10.1016\/j.bcp.2018.01.042_b1340","doi-asserted-by":"crossref","first-page":"21547","DOI":"10.18632\/oncotarget.4249","article-title":"Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001","volume":"6","author":"Ning","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2018.01.042_b1345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2015.07.002","article-title":"NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001","volume":"6","author":"Scicinski","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b1350","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1158\/0008-5472.CAN-11-2303","article-title":"Dinitroazetidines are a novel class of anticancer agents and hypoxia-activated radiation sensitizers developed from highly energetic materials","volume":"72","author":"Ning","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b1355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2010.03.001","article-title":"NO synthase: structures and mechanisms","volume":"23","author":"Daff","year":"2010","journal-title":"Nitric oxide Biol. Chem. Off. J. Nitric Oxide Soc."},{"key":"10.1016\/j.bcp.2018.01.042_b1360","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.278.5337.425","article-title":"The structure of nitric oxide synthase oxygenase domain and inhibitor complexes","volume":"278","author":"Crane","year":"1997","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.bcp.2018.01.042_b1365","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/6675","article-title":"Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation","volume":"6","author":"Fischmann","year":"1999","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b1370","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0092-8674(00)81718-3","article-title":"Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center","volume":"95","author":"Raman","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2018.01.042_b1375","doi-asserted-by":"crossref","first-page":"13868","DOI":"10.1021\/bi020417c","article-title":"The novel binding mode of N-alkyl-N'-hydroxyguanidine to neuronal nitric oxide synthase provides mechanistic insights into NO biosynthesis","volume":"41","author":"Li","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2018.01.042_b1380","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1021\/ja0772041","article-title":"Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors","volume":"130","author":"Ji","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bcp.2018.01.042_b1385","doi-asserted-by":"crossref","first-page":"318087","DOI":"10.1155\/2012\/318087","article-title":"Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges","volume":"2012","author":"Vitecek","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bcp.2018.01.042_b1390","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1039\/C3CS60467E","article-title":"Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain","volume":"43","author":"Mukherjee","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bcp.2018.01.042_b1395","series-title":"Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy","first-page":"3","article-title":"Nitric Oxide and Cancer: An Overview","author":"Cheng","year":"2010"},{"key":"10.1016\/j.bcp.2018.01.042_b1400","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.anndiagpath.2017.01.006","article-title":"The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours","volume":"27","author":"Saied","year":"2017","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.bcp.2018.01.042_b1405","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1089\/ars.2016.6850","article-title":"Inducible nitric oxide synthase in the carcinogenesis of gastrointestinal cancers","volume":"26","author":"de Oliveira","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2018.01.042_b1410","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.tips.2011.07.001","article-title":"Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer","volume":"32","author":"Switzer","year":"2011","journal-title":"Trend Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2018.01.042_b1415","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ygyno.2006.10.049","article-title":"Prognostic significance of iNOS in epithelial ovarian cancer","volume":"105","author":"Anttila","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bcp.2018.01.042_b1420","first-page":"1137","article-title":"High expression of nitric oxide synthases is a favorable prognostic sign in non-small cell lung carcinoma. APMIS: acta pathologica, microbiologica, et immunologica","volume":"111","author":"Puhakka","year":"2003","journal-title":"Scandinavica"},{"key":"10.1016\/j.bcp.2018.01.042_b1425","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.bjp.0706168","article-title":"GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo","volume":"145","author":"Alderton","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1430","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.bjc.6606034","article-title":"The role of tumour-derived iNOS in tumour progression and angiogenesis","volume":"104","author":"Kostourou","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2018.01.042_b1435","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1158\/1078-0432.CCR-09-3123","article-title":"Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy","volume":"16","author":"Sikora","year":"2010","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b1440","doi-asserted-by":"crossref","first-page":"17318","DOI":"10.1074\/jbc.M110.115261","article-title":"Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.01.042_b1445","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-3-319-18144-8_17","article-title":"Phosphinodithioate and phosphoramidodithioate hydrogen sulfide donors","volume":"230","author":"Whiteman","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1450","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1464-410X.2009.08415.x","article-title":"Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats","volume":"103","author":"Shukla","year":"2009","journal-title":"BJU Int."},{"key":"10.1016\/j.bcp.2018.01.042_b1455","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/glia.20905","article-title":"Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation","volume":"58","author":"Lee","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2018.01.042_b1460","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.bmcl.2009.02.007","article-title":"New prostaglandin derivative for glaucoma treatment","volume":"19","author":"Perrino","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2018.01.042_b1465","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1586\/ecp.10.122","article-title":"Therapeutic potential of new hydrogen sulfide-releasing hybrids","volume":"4","author":"Sparatore","year":"2011","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1470","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1269\/jrr.11004","article-title":"Hydrogen sulfide contributes to hypoxia-induced radioresistance on hepatoma cells","volume":"52","author":"Zhang","year":"2011","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.bcp.2018.01.042_b1475","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/bph.12171","article-title":"Selectivity of commonly used pharmacological inhibitors for cystathionine beta synthase (CBS) and cystathionine gamma lyase (CSE)","volume":"169","author":"Asimakopoulou","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1480","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/1535-7163.MCT-15-0691-T","article-title":"A fast hydrogen sulfide-releasing donor increases the tumor response to radiotherapy","volume":"15","author":"De Preter","year":"2016","journal-title":"Mol. Cancer Therap."},{"key":"10.1016\/j.bcp.2018.01.042_b1485","first-page":"479","article-title":"Inhibition of hydrogen sulphide formation reduces cisplatin-induced renal damage","volume":"26","author":"Della Coletta Francescato","year":"2011","journal-title":"Nephrol. Dial. Transplant. Off. Pub. Eur. Dial. Transpl. Assoc. Eur. Renal Assoc."},{"key":"10.1016\/j.bcp.2018.01.042_b1490","first-page":"121","article-title":"Hydrogen sulfide ameliorates the kidney dysfunction and damage in cisplatin-induced nephrotoxicity in rat","volume":"5","author":"Ahangarpour","year":"2014","journal-title":"Vet. Res. Forum Int. quart. J"},{"key":"10.1016\/j.bcp.2018.01.042_b1495","doi-asserted-by":"crossref","first-page":"8145785","DOI":"10.1155\/2016\/8145785","article-title":"A H 2 S Donor GYY4137 Exacerbates Cisplatin-Induced Nephrotoxicity in Mice","volume":"2016","author":"Liu","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bcp.2018.01.042_b1500","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/CIRCULATIONAHA.107.753467","article-title":"Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide","volume":"117","author":"Li","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2018.01.042_b1505","doi-asserted-by":"crossref","first-page":"e21077","DOI":"10.1371\/journal.pone.0021077","article-title":"The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo","volume":"6","author":"Lee","year":"2011","journal-title":"PloS one"},{"key":"10.1016\/j.bcp.2018.01.042_b1510","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3892\/ijo.2014.2305","article-title":"GYY4137, a hydrogen sulfide (H(2)S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway","volume":"44","author":"Lu","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bcp.2018.01.042_b1515","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1111\/bph.12773","article-title":"Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance","volume":"171","author":"Lee","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1520","first-page":"97","article-title":"A comparative study of the effects of carbon monoxide and methylene chloride on human performance","volume":"2","author":"Putz","year":"1979","journal-title":"J. Environ. Pathol. Toxicol."},{"key":"10.1016\/j.bcp.2018.01.042_b1525","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/bmj.281.6253.1461","article-title":"Carbon monoxide poisoning secondary to inhaling methylene chloride","volume":"281","author":"Fagin","year":"1980","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bcp.2018.01.042_b1530","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/bph.12760","article-title":"Diverse mechanisms underlying the regulation of ion channels by carbon monoxide","volume":"172","author":"Peers","year":"2015","journal-title":"Br. J pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1535","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1113\/expphysiol.2011.057422","article-title":"Emerging roles for gasotransmitters","volume":"96","author":"Peers","year":"2011","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.bcp.2018.01.042_b1540","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/SHK.0000000000000264","article-title":"Carbon monoxide protects against hemorrhagic shock and resuscitation-induced microcirculatory injury and tissue injury","volume":"43","author":"Nassour","year":"2015","journal-title":"Shock"},{"key":"10.1016\/j.bcp.2018.01.042_b1545","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/ars.2013.5308","article-title":"Anti-cancer activity of new designer hydrogen sulfide-donating hybrids","volume":"20","author":"Kashfi","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2018.01.042_b1550","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bcp.2011.12.019","article-title":"Hydrogen sulfide-releasing aspirin suppresses NF-kappaB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo","volume":"83","author":"Chattopadhyay","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1555","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.bcp.2011.12.018","article-title":"Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect","volume":"83","author":"Chattopadhyay","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1560","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bcp.2011.12.020","article-title":"Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo","volume":"83","author":"Chattopadhyay","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1565","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.niox.2014.04.006","article-title":"Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer","volume":"41","author":"Elsheikh","year":"2014","journal-title":"Nitric oxide Biol. Chem. Off. J. Nitric Oxide Soc."},{"key":"10.1016\/j.bcp.2018.01.042_b1570","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.phrs.2016.10.019","article-title":"ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo","volume":"114","author":"De Cicco","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2018.01.042_b1575","doi-asserted-by":"crossref","first-page":"e0147289","DOI":"10.1371\/journal.pone.0147289","article-title":"Profound chemopreventative effects of a hydrogen sulfide-releasing NSAID in the APCMin\/+ mouse model of intestinal tumorigenesis","volume":"11","author":"Paul-Clark","year":"2016","journal-title":"PloS one"},{"key":"10.1016\/j.bcp.2018.01.042_b1580","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/2045-9912-3-24","article-title":"A comparative study on the anti-inflammatory effects of single oral doses of naproxen and its hydrogen sulfide (H2S)-releasing derivative ATB-346 in rats with carrageenan-induced synovitis","volume":"3","author":"Ekundi-Valentim","year":"2013","journal-title":"Med. Gas Res."},{"key":"10.1016\/j.bcp.2018.01.042_b1585","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejmech.2017.06.012","article-title":"Syntheses, toxicities and anti-inflammation of H2S-donors based on non-steroidal anti-inflammatory drugs","volume":"138","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2018.01.042_b1590","first-page":"4","article-title":"Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potential","author":"Kodela","year":"2013","journal-title":"MedChemComm."},{"key":"10.1016\/j.bcp.2018.01.042_b1595","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.freeradbiomed.2009.04.014","article-title":"GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat","volume":"47","author":"Li","year":"2009","journal-title":"Free Rad. Biol. Med."},{"key":"10.1016\/j.bcp.2018.01.042_b1600","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.freeradbiomed.2006.12.011","article-title":"Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative","volume":"42","author":"Li","year":"2007","journal-title":"Free Rad. Biol. Med."},{"key":"10.1016\/j.bcp.2018.01.042_b1605","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1158\/0008-5472.CAN-11-3115","article-title":"Dithiolethiones inhibit NF-kappaB activity via covalent modification in human estrogen receptor-negative breast cancer","volume":"72","author":"Switzer","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b1610","first-page":"4873","article-title":"Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-kappaB signaling","volume":"9","author":"Kodela","year":"2015","journal-title":"Drug Des. Dev. Therap."},{"key":"10.1016\/j.bcp.2018.01.042_b1615","doi-asserted-by":"crossref","unstructured":"Z. Gan M. Chattopadhyay R. Kodela D. Boring J. Crowell K. Kashfi, Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates \u03b2-catenin expression, American Association for Cancer Research, 102nd Annual Meeting, April 2\u20136, Orlando FL 2011.","DOI":"10.1158\/1538-7445.AM2011-4608"},{"key":"10.1016\/j.bcp.2018.01.042_b1620","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1021\/ml300002m","article-title":"NOSH-aspirin: a novel nitric oxide-hydrogen sulfide-releasing hybrid: a new class of anti-inflammatory pharmaceuticals","volume":"3","author":"Kodela","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2018.01.042_b1625","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bcp.2015.09.014","article-title":"NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications","volume":"98","author":"Kodela","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1630","doi-asserted-by":"crossref","first-page":"e00224","DOI":"10.1002\/prp2.224","article-title":"Gastrointestinal safety, chemotherapeutic potential, and classic pharmacological profile of NOSH-naproxen (AVT-219) a dual NO- and H2S-releasing hybrid","volume":"4","author":"Chattopadhyay","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bcp.2018.01.042_b1635","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.redox.2015.08.012","article-title":"NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties","volume":"6","author":"Kashfi","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2018.01.042_b1640","doi-asserted-by":"crossref","first-page":"e00133","DOI":"10.1002\/prp2.133","article-title":"NOSH-aspirin (NBS-1120), a dual nitric oxide and hydrogen sulfide-releasing hybrid, reduces inflammatory pain","volume":"3","author":"Fonseca","year":"2015","journal-title":"Pharmacol. Res. Persp."},{"key":"10.1016\/j.bcp.2018.01.042_b1645","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1124\/jpet.110.171017","article-title":"Comparison between 3-nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as safe anti-inflammatory, analgesic, antipyretic, antioxidant prodrugs","volume":"335","author":"Chattopadhyay","year":"2010","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.bcp.2018.01.042_b1650","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1476-5381.2010.01191.x","article-title":"Hydrogen sulphide and angiogenesis: mechanisms and applications","volume":"164","author":"Szabo","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1655","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/CS20110267","article-title":"Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools","volume":"121","author":"Whiteman","year":"2011","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bcp.2018.01.042_b1660","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.niox.2014.04.008","article-title":"AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro","volume":"41","author":"Szczesny","year":"2014","journal-title":"Nitric Oxide Biol. Chem. Off. J. Nitric Oxide Soc."},{"key":"10.1016\/j.bcp.2018.01.042_b1665","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1124\/jpet.105.091595","article-title":"Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels","volume":"316","author":"Distrutti","year":"2006","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.bcp.2018.01.042_b1670","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1124\/jpet.106.106435","article-title":"5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity","volume":"319","author":"Distrutti","year":"2006","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.bcp.2018.01.042_b1675","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1476-5381.2010.00640.x","article-title":"Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat","volume":"159","author":"Ekundi-Valentim","year":"2010","journal-title":"Br. J Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1680","doi-asserted-by":"crossref","first-page":"G467","DOI":"10.1152\/ajpgi.00169.2013","article-title":"Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments","volume":"305","author":"Chan","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bcp.2018.01.042_b1685","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.bjp.0707193","article-title":"Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis","volume":"150","author":"Fiorucci","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.042_b1690","doi-asserted-by":"crossref","first-page":"65677","DOI":"10.18632\/oncotarget.20057","article-title":"Cystathionine- gamma-lyase promotes process of breast cancer in association with STAT3 signaling pathway","volume":"8","author":"You","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2018.01.042_b1695","first-page":"171","article-title":"Hydrogen sulfide generation from l-cysteine in the human glioblastoma-astrocytoma U-87 MG and neuroblastoma SHSY5Y cell lines","volume":"64","author":"Bronowicka-Adamska","year":"2017","journal-title":"Acta Biochim. Polon."},{"key":"10.1016\/j.bcp.2018.01.042_b1700","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.cellsig.2014.08.023","article-title":"Wnt\/beta-catenin signaling induces the transcription of cystathionine-gamma-lyase, a stimulator of tumor in colon cancer","volume":"26","author":"Fan","year":"2014","journal-title":"Cell. Signall."},{"key":"10.1016\/j.bcp.2018.01.042_b1705","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/1541-7786.MCR-14-0184","article-title":"Decreased expression of cystathionine beta-synthase promotes glioma tumorigenesis","volume":"12","author":"Takano","year":"2014","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.bcp.2018.01.042_b1710","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s002689900165","article-title":"Effect of supplemental L-arginine in a chemical-induced model of colorectal cancer","volume":"20","author":"Ma","year":"1996","journal-title":"World J. Surg."},{"key":"10.1016\/j.bcp.2018.01.042_b1715","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jnutbio.2009.03.005","article-title":"Effect of arginine on angiogenesis induced by human colon cancer: in vitro and in vivo studies","volume":"21","author":"Yeh","year":"2010","journal-title":"J. Nutrit. Biochem."},{"key":"10.1016\/j.bcp.2018.01.042_b1720","doi-asserted-by":"crossref","first-page":"7407","DOI":"10.1158\/1078-0432.CCR-07-0751","article-title":"L-arginine reduces cell proliferation and ornithine decarboxylase activity in patients with colorectal adenoma and adenocarcinoma","volume":"13","author":"Ma","year":"2007","journal-title":"Clin. Cancer Res. Off. J. Am. Associat. Cancer Res."},{"key":"10.1016\/j.bcp.2018.01.042_b1725","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jgm.1280","article-title":"Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells","volume":"11","author":"Adams","year":"2009","journal-title":"J. Gene Med."},{"key":"10.1016\/j.bcp.2018.01.042_b1730","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1089-8603(02)00147-7","article-title":"Overexpression of the human inducible nitric oxide synthase gene enhances radiation-induced apoptosis in colorectal cancer cells via a caspase-dependent mechanism","volume":"8","author":"Chung","year":"2003","journal-title":"Nitric Oxide: Biol. Chem. Off. J. Nitric Oxide Soc."},{"key":"10.1016\/j.bcp.2018.01.042_b1735","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/1521-2254(200009\/10)2:5<344::AID-JGM124>3.0.CO;2-3","article-title":"Gene therapy of rat medullary thyroid cancer by naked nitric oxide synthase II DNA injection","volume":"2","author":"Soler","year":"2000","journal-title":"J. Gene Med."},{"key":"10.1016\/j.bcp.2018.01.042_b1740","doi-asserted-by":"crossref","first-page":"8758","DOI":"10.1073\/pnas.0409581102","article-title":"Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors","volume":"102","author":"Le","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b1745","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/cbr.1997.12.167","article-title":"Use of retroviral vectors encoding murine inducible nitric oxide synthase gene to suppress tumorigenicity and cancer metastasis of murine melanoma","volume":"12","author":"Juang","year":"1997","journal-title":"Cancer Biotherap. Radiopharm."},{"key":"10.1016\/j.bcp.2018.01.042_b1750","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1053\/gast.2003.50096","article-title":"Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study","volume":"124","author":"Fiorucci","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2018.01.042_b1755","doi-asserted-by":"crossref","first-page":"10937","DOI":"10.1073\/pnas.1933204100","article-title":"Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa","volume":"100","author":"Fiorucci","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.01.042_b1760","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2004.03.079","article-title":"Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans","volume":"44","author":"Fiorucci","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2018.01.042_b1765","unstructured":"NicOx SA. NicOx provides an update on NCX-4016. Sophia Antipolis, France. http:\/\/www.nicox.com\/wp-content\/uploads\/pr2007061800en.pdf?4051a2, 2007."},{"key":"10.1016\/j.bcp.2018.01.042_b1770","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.semarthrit.2010.06.002","article-title":"Efficacy and safety of naproxcinod in patients with osteoarthritis of the knee: a 53-week prospective randomized multicenter study","volume":"40","author":"Schnitzer","year":"2011","journal-title":"Sem. Arthrit. Rheumat."},{"key":"10.1016\/j.bcp.2018.01.042_b1775","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.joca.2009.12.013","article-title":"Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study","volume":"18","author":"Schnitzer","year":"2010","journal-title":"Osteoarthrit. Cartil. OARS, Osteoarth. Res. Soc."},{"key":"10.1016\/j.bcp.2018.01.042_b1780","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3899\/jrheum.081011","article-title":"Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee","volume":"36","author":"Karlsson","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bcp.2018.01.042_b1785","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/art.21586","article-title":"Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee","volume":"53","author":"Schnitzer","year":"2005","journal-title":"Arthrit. Rheumat."},{"key":"10.1016\/j.bcp.2018.01.042_b1790","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/ard.2004.023572","article-title":"A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis","volume":"64","author":"Lohmander","year":"2005","journal-title":"Ann. Rheumat. Diseas."},{"key":"10.1016\/j.bcp.2018.01.042_b1795","unstructured":"NicOx SA. FDA provides Complete Response Letter to NicOx's New Drug Application for naproxcinod. http:\/\/www.nicox.com\/wp-content\/uploads\/pr2010072200en.pdf?aeb643, 2010."},{"key":"10.1016\/j.bcp.2018.01.042_b1800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.104.080564","article-title":"Cancer prevention: a new era beyond cyclooxygenase-2","volume":"314","author":"Rigas","year":"2005","journal-title":"J. Pharmacol. Exp. Therap."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218300480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218300480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:40:38Z","timestamp":1751402438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218300480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":360,"alternative-id":["S0006295218300480"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2018.01.042","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The dichotomous role of H2S in cancer cell biology? D\u00e9j\u00e0 vu all over again","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2018.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}